224 related articles for article (PubMed ID: 23704969)
21. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Hu Z; Hu X; Long J; Su L; Wei B
Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
[TBL] [Abstract][Full Text] [Related]
23. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
24. Association between the XRCC1 polymorphisms and thyroid cancer risk: a meta-analysis from case-control studies.
Wu FF; He XF; Shen HW; Qin GJ
PLoS One; 2014; 9(9):e87764. PubMed ID: 25211472
[TBL] [Abstract][Full Text] [Related]
25. Association between XRCC1 polymorphisms and laryngeal cancer susceptibility in a Chinese sample population.
Wu WQ; Zhang LS; Liao SP; Lin XL; Zeng J; Du D
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808358
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
[TBL] [Abstract][Full Text] [Related]
27. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Li C; Xiang X; Zhou Y
Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
[TBL] [Abstract][Full Text] [Related]
28. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
29. Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.
Mao Y; Xu X; Lin Y; Chen H; Wu J; Hu Z; Zhu Y; Xu X; Xie L
World J Surg Oncol; 2013 Mar; 11():58. PubMed ID: 23496911
[TBL] [Abstract][Full Text] [Related]
30. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis.
Zhou C; Zhou Y; Li J; Zhang Y; Jiang L; Zeng X; Feng X; Wang Z
Tohoku J Exp Med; 2009 Sep; 219(1):43-51. PubMed ID: 19713684
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis.
Shuai HL; Luo X; Yan RL; Li J; Chen DL
Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469
[TBL] [Abstract][Full Text] [Related]
32. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between polymorphisms of X-ray repair cross-complementing group 1 gene Arg194Trp, Arg399Gln and susceptibility of breast cancer].
Qian Y; Zhang JP; Dong J; Wang FR; Lin YD; Xu M; Wu LL; Shi P; Shen HB
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):242-6. PubMed ID: 20450747
[TBL] [Abstract][Full Text] [Related]
34. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
36. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
37. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.
Liu L; Miao L; Ji G; Qiang F; Liu Z; Fan Z
Mol Biol Rep; 2013 Jun; 40(6):3943-52. PubMed ID: 23271134
[TBL] [Abstract][Full Text] [Related]
38. Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population.
Wang LJ; Wang HT; Wang XX
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323136
[TBL] [Abstract][Full Text] [Related]
39. New Concept of X-Ray Repair Cross-Complementing Groups 1 Polymorphisms and Gynecologic Cancer Risk.
Du Y; Wang H; Lv B
Gynecol Obstet Invest; 2018; 83(1):15-22. PubMed ID: 28391259
[TBL] [Abstract][Full Text] [Related]
40. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
